181 related articles for article (PubMed ID: 27461215)
21. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
[TBL] [Abstract][Full Text] [Related]
22. Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
Ruggiero B; Trillini M; Tartaglione L; Rotondi S; Perticucci E; Tripepi R; Aparicio C; Lecchi V; Perna A; Peraro F; Villa D; Ferrari S; Cannata A; Mazzaferro S; Mallamaci F; Zoccali C; Bellasi A; Cozzolino M; Remuzzi G; Ruggenenti P; Kohan DE;
Am J Kidney Dis; 2019 Sep; 74(3):338-350. PubMed ID: 31027883
[TBL] [Abstract][Full Text] [Related]
23. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
Katsumata K; Kusano K; Hirata M; Tsunemi K; Nagano N; Burke SK; Fukushima N
Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.
Skafi N; Abdallah D; Soulage C; Reibel S; Vitale N; Hamade E; Faour W; Magne D; Badran B; Hussein N; Buchet R; Brizuela L; Mebarek S
J Cell Physiol; 2019 Apr; 234(4):4825-4839. PubMed ID: 30207376
[TBL] [Abstract][Full Text] [Related]
25. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
26. Calcitriol Accelerates Vascular Calcification Irrespective of Vitamin K Status in a Rat Model of Chronic Kidney Disease with Hyperphosphatemia and Secondary Hyperparathyroidism.
McCabe KM; Zelt JG; Kaufmann M; Laverty K; Ward E; Barron H; Jones G; Adams MA; Holden RM
J Pharmacol Exp Ther; 2018 Sep; 366(3):433-445. PubMed ID: 29903718
[TBL] [Abstract][Full Text] [Related]
27. [Pleiotropic effects of sevelamer: a model of intestinal tract chelating agent].
Massy ZA; Maizel J
Nephrol Ther; 2014 Nov; 10(6):441-50. PubMed ID: 25070605
[TBL] [Abstract][Full Text] [Related]
28. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
29. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Patel L; Bernard LM; Elder GJ
Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
[TBL] [Abstract][Full Text] [Related]
30. Current and potential treatment options for hyperphosphatemia.
Carfagna F; Del Vecchio L; Pontoriero G; Locatelli F
Expert Opin Drug Saf; 2018 Jun; 17(6):597-607. PubMed ID: 29783873
[TBL] [Abstract][Full Text] [Related]
31. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
[TBL] [Abstract][Full Text] [Related]
32. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy.
Mathew S; Lund RJ; Strebeck F; Tustison KS; Geurs T; Hruska KA
J Am Soc Nephrol; 2007 Jan; 18(1):122-30. PubMed ID: 17182886
[TBL] [Abstract][Full Text] [Related]
33. Use of sevelamer in chronic kidney disease: beyond phosphorus control.
Rodríguez-Osorio L; Zambrano DP; Gracia-Iguacel C; Rojas-Rivera J; Ortiz A; Egido J; González Parra E
Nefrologia; 2015; 35(2):207-17. PubMed ID: 26300515
[TBL] [Abstract][Full Text] [Related]
34. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
Tokumoto M; Mizobuchi M; Finch JL; Nakamura H; Martin DR; Slatopolsky E
Am J Nephrol; 2009; 29(6):582-91. PubMed ID: 19145073
[TBL] [Abstract][Full Text] [Related]
35. Effect of Sevelamer on Serum Levels of Klotho and Soluble Tumor Necrosis Factor-like Weak Inducer of Apoptosis in Rats With Adenine-induced Chronic Kidney Disease.
Golmohamadi Z; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Bargahi N; Mesgari M; Sanajou D
Iran J Kidney Dis; 2018 Oct; 12(5):281-287. PubMed ID: 30367019
[TBL] [Abstract][Full Text] [Related]
36. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.
Han X; Wang LY; Diao ZL; Liu WH
Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047
[TBL] [Abstract][Full Text] [Related]
37. Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29146611
[TBL] [Abstract][Full Text] [Related]
38. Chronic Kidney Disease-Induced Arterial Media Calcification in Rats Prevented by Tissue Non-Specific Alkaline Phosphatase Substrate Supplementation Rather Than Inhibition of the Enzyme.
Opdebeeck B; Neven E; Millán JL; Pinkerton AB; D'Haese PC; Verhulst A
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452102
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of Extracellular Pyrophosphate Increases in Vascular Smooth Muscle Cells During Phosphate-Induced Calcification.
Villa-Bellosta R
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2137-2147. PubMed ID: 30002059
[TBL] [Abstract][Full Text] [Related]
40. Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.
Chen N; Wu X; Ding X; Mei C; Fu P; Jiang G; Li X; Chen J; Liu B; La Y; Hou F; Ni Z; Fu J; Xing C; Yu X; Huang C; Zuo L; Wang L; Hunter J; Dillon M; Plone M; Neylan J
Nephrol Dial Transplant; 2014 Jan; 29(1):152-60. PubMed ID: 24151017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
